CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy (Q34155045)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy |
scientific article |
Statements
1 reference
CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy (English)
1 reference
Adam Siddiqui-Jain
1 reference
Denis Drygin
1 reference
Nicole Streiner
1 reference
Peter Chua
1 reference
Fabrice Pierre
1 reference
Sean E O'Brien
1 reference
Josh Bliesath
1 reference
Mayuko Omori
1 reference
Nanni Huser
1 reference
Caroline Ho
1 reference
Chris Proffitt
1 reference
Michael K Schwaebe
1 reference
David M Ryckman
1 reference
William G Rice
1 reference
Kenna Anderes
1 reference
1 December 2010
1 reference
1 reference
Identifiers
1 reference